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Abstract Familial hemiplegic migraine type 1 (FHM1) is a
rare monogenic subtype of migraine with aura caused by mu-
tations in CACNA1A that encodes the α1A subunit of voltage-
gated CaV2.1 calcium channels. Transgenic knock-in mice
that carry the human FHM1 R192Q missense mutation
(‘FHM1 R192Q mice’) exhibit an increased susceptibility to
cortical spreading depression (CSD), the mechanism underly-
ing migraine aura. Here, we analysed gene expression profiles
from isolated cortical tissue of FHM1 R192Q mice 24 h after
experimentally induced CSD in order to identify molecular
pathways affected by CSD. Gene expression profiles were
generated using deep serial analysis of gene expression se-
quencing. Our data reveal a signature of inflammatory signal-
ling upon CSD in the cortex of both mutant and wild-type
mice. However, only in the brains of FHM1 R192Q mice
specific genes are up-regulated in response to CSD that are
implicated in interferon-related inflammatory signalling. Our
findings show that CSDmodulates inflammatory processes in
both wild-type and mutant brains, but that an additional
unique inflammatory signature becomes expressed after
CSD in a relevant mouse model of migraine.
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Introduction
Migraine is a common brain disorder that is characterised by
attacks of severe unilateral headaches accompanied by nausea,
vomiting, phono- and/or photophobia [1]. In up to a third of
patients, attacks can be accompanied by transient focal neuro-
logical aura symptoms that are mostly visual in nature. The
likely cause of the aura is cortical spreading depression
(CSD), a slow self-propagating wave of neuronal and glial
depolarization that originates in the caudal (occipital) cortex
and travels frontal through the cortex and is followed by long-
lasting temporary neuronal silencing [2, 3]. Experiments in
animals revealed that CSD can activate meningeal
trigeminovascular neurons and thereby trigeminal ganglia
and centres in the brainstem, which confer nociceptive signals
further to thalamic and cortical areas that ultimately lead to the
sensation of pain [4–8].Within minutes after CSD, opening of
neuronal Pannexin-1 channels triggers an inflammatory cas-
cade in neurons and glial cells that is thought to be responsible
for the activation of peripheral and central trigeminovascular
neurons [8]. In wild-type mice, CSD causes a pronounced
sustained up-regulation of genes involved in inflammation,
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oxidative stress and intracellular signalling [9–12], but at pres-
ent, it is unclear to what extent this is also relevant to migraine
pathophysiology.
Therefore, we set out to identify changes in gene
expression in response to CSD in a transgenic mouse
model of familial hemiplegic migraine type 1 (FHM1),
which is considered also a relevant model for the com-
mon forms of migraine [13]. FHM1 is a rare monogenic
subtype of migraine with aura characterised by motor
weakness during the aura [1]. FHM1 is caused by mu-
tations in CACNA1A gene that codes for the pore-
forming α1A subunit of neuronal voltage-gated CaV2.1
channels [14]. Mice that express mutated CaV2.1 chan-
nels containing the FHM1 R192Q missense mutation
(‘FHM1 R192Q mice’) exhibit an increased susceptibil-
ity to CSD due to increased neuronal calcium influx
through CaV2.1 channels and increased cortical gluta-
matergic neurotransmission [15–17]. We used deep seri-
al analysis of gene expression (DeepSAGE) sequencing
to identify gene expression changes in the cortex of
wild-type (WT) and FHM1 R192Q mice that were sub-
jected to multiple CSD events. To ensure that the gene
expression results would not reflect the anaesthesia or
surgical procedure, Sham surgery was applied in sepa-
rate groups of WT and R192Q animals. Tissue was har-
vested 24 h after the procedure—a time point at which
gene expression is known to be affected by CSD [12]—
to minimise the effects of the anaesthesia and surgery
on gene expression profiles. Several pathway analysis
methods were applied to gain insight into the mecha-
nisms that are differentially affected by CSD in the
FHM1 R192Q mice compared with WT mice, in order




For this study, we used 2- to 4-month-old male WT mice and
homozygous transgenic FHM1 mice that carry the human
CACNA1A R192Q missense mutation (FHM1 R192Q mice).
Transgenic mutant mice were generated by introducing the
human pathogenic R192Q mutation in the endogenous
Cacna1a gene using a gene targeting approach [15]. FHM1
R192Q mice of this study were backcrossed to C57BL/6J for
six generations. All experimental groups consisted of six
mice. Mice were maintained on a normal 12:12 light/dark
cycle and water and food were available ad libitum. All pro-
cedures were approved by the local Leiden University Medi-
cal Center Animal Experiments Ethics Committee.
Induction of CSD and Tissue Isolation
Mice were anaesthetized using 1.5 % isoflurane in pressurised
air (20 % O2 and 80 % N2) and placed onto a stereotactic
frame (David Kopf Instruments, Tujunga, CA, USA). Core
body temperature was maintained at 37 °C with a heating
pad. After exposure of the skull two burr holes were prepared
at the following coordinates over the right hemisphere for: (i)
CSD induction on the occipital cortex (3.5 mm posterior,
2 mm lateral from bregma) and (ii) CSD recording from the
frontal cortex (1.5mm anterior, 2 mm lateral from bregma). At
the recording site in the frontal cortex, a sharp glass capillary
electrode (FHC Inc., Bowdoin, ME, USA) filled with 150mM
NaCl was advanced to a depth of 200–300 μm. Data were
sampled (200 Hz), amplified (10×) and low-pass filtered at
4 Hz and analysed off-line using LabChart (AD Instruments,
Colorado Springs, CO, USA). A reversible DC deflection that
was >5 mV in amplitude was considered a CSD event. Seven
CSDs were induced by brief application (30 s) of a cotton
pellet (Interguide Dental Supply, Burlingame, CA, USA)
soaked in 300 mM KCl on the dura overlaying the occipital
cortex. Between each KCl application the stimulation area
was thoroughly rinsed with saline. The inter-application inter-
val was 5 min; each application induced a single CSD, both in
WTand mutant mice. In Sham-treated animals 300 mMNaCl
was applied seven times, instead of KCl; NaCl application did
not induce CSDs, neither in WT nor in mutant mice. Mice
received a subcutaneous injection of 5 mg/kg carprofen for
post-operative analgesia after the last CSD or the last NaCl
application. Five minutes after the 7th CSD induction or 7th
NaCl application, the skin overlaying the skull was sutured
and the mice were returned to their home cages to recover
from surgery under a heating lamp (37 °C). Twenty-four hours
after the end of the CSD or Sham procedure, animals were
sacrificed by cervical dislocation. The middle one third of the
right hemisphere cortex—through which the CSD waves had
passed—that was located between the other thirds that
contained either the stimulation (occipital cortex) or the re-
cording (frontal cortex) burr hole was isolated (Fig. 1). After
visual inspection to confirm that the cortical tissue did not
show obvious damage caused by the surgery or CSD/Sham
procedure, tissue was snap frozen in liquid N2 within 15 min
from the moment of sacrifice, and stored at −80 °C until RNA
isolation.
RNA Isolation
Frozen tissue of the middle third part of the cortex was
crunched using a mortar and subsequently homogenised in
lysis buffer using the Ultra-turrax T25 Polytron (Janke &
Kunkel, Staufen, Germany) mechanical homogeniser. Total
RNA was isolated using the Nucleospin RNA II RNA isola-
tion kit (Machery-Nagel, Düren, Germany). Contaminating
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DNA was removed by on-column treatment with rDNase.
Agilent 2100 Bioanalyzer total RNA nanochips (Agilent, Fos-
ter City, CA, USA) were used to determine RNA integrity.
RNA samples included in this study had RIN (RNA integrity
number) values between 8.9 and 10.
Gene Expression Profiling Using DeepSAGE Sequencing
DeepSAGE libraries were produced and sequenced according
to the Illumina protocol by the Leiden Genome Technology
Center (LGTC, Leiden, the Netherlands), as described previ-
ously [18]. In brief, mRNA was hybridised to Oligo(dT)
beads. On the beads, double-stranded complementary DNA
(cDNA) was synthesised, which was digested with Nlalll and
Mmel restriction enzymes to create a 17-base-pair (bp) cDNA
sequence. The sequence was flanked by two GEX adapters
and amplified by PCR for 15 cycles, during which a 6-bp
barcode index was introduced that allowed discrimination of
reads from up to 12 different samples after sequencing. Li-
brary quality and concentration was checked on a high sensi-
tivity DNA assay (Agilent), after which they were sequenced
on an Illumina HiSeq2000 sequencer (Illumina, San Diego,
CA, USA).
Processing of the Sequencing Data
The quality of the sequencing results was summarised and
plotted using the FASTQ Summary Statistics tool of Galaxy
(http://galaxy.psu.edu). Only samples with at least ten million
reads were included in the analysis. First, all reads were
trimmed to 17 bps to equalise the length of all reads, after
which the Nlalll recognition site sequence (CATG) was added
to the 5′ end of the reads, creating reads with a length of
21 bps. The reads were aligned against the UCSCmm9mouse
genome using Bowtie short read aligner (version 0.12.9),
allowing for a maximum of one mismatch and a maximum
of one possible position in the genome (options: -k 1 -m 1 -n 1
–best –strata). Mouse exon annotation information was re-
trieved from BIOMART (Ensembl build 64), and was used
to calculate the number of reads per gene for each sample.
Only reads aligned to known exons in the sense direction were
used for downstream statistical and biological analyses. Anal-
yses were performed at gene level, and reads were summed
per gene also when aligned to different locations within a
gene, e.g. as a consequence of alternative polyadenylation.
Raw gene expression data has been submitted to the Gene
Expression Omnibus under accession number GSE67933.
Statistical Analysis
Statistical analysis of the DeepSAGE sequencing data was
performed in R (version 2.15.2) using the Bioconductor
package EdgeR (version 3.0.8) [19]. To account for dif-
ferences in library size, the data was first normalised
using the trimmed mean of M-values (TMM) method. A
multifactorial generalised linear model was used to calcu-
late the genotype (comparing both FHM1 R192Q and
both WT groups) and CSD effects (comparing both
CSD-treated with both Sham-treated groups). A second
multifactorial model including an intercept term was used
to calculate the interaction between genotype and CSD. In
both models, the Cox-Reid profile-adjusted likelihood
(CR) method was used to estimate the common disper-
sion. Subsequently, the mean-variance trend was
accounted for, and the tag-wise dispersion was calculated
as a linear combination of the trended dispersion and the
tag-wise dispersion. The amount of shrinkage towards the
common dispersion was defined by setting a prior n of
10. Finally, differential expression was determined using
the generalised linear model likelihood ratio test. For the
factors genotype and CSD, as well as for the interaction
factor, genes with nominal p values ≤0.005 were used for
Fig. 1 Overview of the experimental procedures for CSD induction,
recording and cortical tissue isolation. CSD induction: CSD events
were induced under isoflurane anaesthesia by 30-s application of
300 mM KCl (‘CSD-treated’; or 300 mM NaCl for ‘Sham-treated’
groups) on a craniotomy window overlaying the occipital cortex while
DC-potential recordings were made from a glass electrode in the frontal
cortex. CSD recording: induction of seven CSD waves was obtained by
seven applications of KCl, each eliciting a single CSD event in both WT
and FHM1 R192Q mutant mice, at 5-min intervals. Sham surgery with
application of 300 mM NaCl did not elicit CSD events. Tissue isolation
24 h post-CSD: 24 h after the end of the CSD or Sham procedure brain
tissue was isolated. The middle part of the right-sided cortex (including
parietal cortex), through which the CSD waves travelled (hashed area),
was dissected for RNA profiling
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downstream analysis. In an earlier gene expression study
in which we compared naïve cortical gene expression
levels from FHM1 mice with WT mice, we found an
overrepresentation of differentially expressed genes from
chromosome 8 resulting from remaining 129/Ola-derived
genetic background that was present as a consequence of
the gene targeting procedure [20]. Therefore, we removed
all genes from chromosome 8 from the genotype effect
gene list. Furthermore, genes passing the significance
threshold for the interaction factor were removed from
the genotype and/or CSD effect lists as they may not
reflect a pure genotype or pure CSD effect. Clustering
analysis was performed to classify genes according to
their expression patterns over the four experimental
groups. First, TMM normalised gene expression levels
were averaged per experimental group, and the mean
and variance were standardised. Next, the expression pat-
terns were clustered by using the k-means method to di-
vide the genes into four groups (settings: number of clus-
ters is ‘4’, method = ‘correlation’).
Functional Annotation of Gene Sets
To identify overrepresented functional categories in a gene
list, gene set enrichment of the PANTHER subset of biological
process gene ontology (GO) terms and pathways was per-
formed using DAVID (version 6.7; http://david.abcc.ncifcrf.
gov/). Only GO terms and pathways represented by five or
more genes from the gene list and with a p value <0.05 were
considered significant. The STRING database for known and
predicted protein-protein interactions (PPIs; version 9.05,
http://string-db.org/) [21] was used to identify physical and
functional associations between proteins within a gene list.
Information from the STRING database based on genomic
context, high-throughput experiments, co-expression as well
as text mining was used to create protein association
networks.
The CORE_TF database for conserved and overrepresent-
ed t ranscr ipt ion factors (ht tp: / /grenada. lumc.nl /
HumaneGenetica/CORE_TF/) [22] was used to identify
transcription factor binding sites in the promoter regions
(1000 bp upstream of exon 1) from a gene l is t .
Overrepresentation of transcription factor binding sites was
calculated by comparing with a set of 3000 random
promoters with similar GC content. Only transcription
factors with a binding site frequency of 10 % or more in the
random set of promoters were considered. Transcription factor
binding sites were linked to transcription factors using
information from the molecular signatures database (http://
www.broadinstitute.org/gsea/index.jsp). The Interferome
database was used to identify interferon-regulated genes in a
gene list (version 2.1, standard settings, http://interferome.its.
monash.edu.au/interferome/home.jspx) [23].
Primer Design and Quantitative PCR
An independent set of RNA samples (N=6 for each of the
four experimental groups) was used for validation of the
DeepSAGE sequencing results by real-time quantitative
PCR (RT-qPCR). Upon RNA isolation, first-strand cDNA
was synthesised using the RevertAid First-Strand cDNA Syn-
thesis Kit (Thermo Scientific Fermentas, Vilnius, Lithuania).
Subsequently, RT-qPCRs were performed on the CFX384
Real-Time PCR Detection System (Bio-Rad, Hercules, CA,
USA) using iQ™ SYBR®Green (Bio-Rad) and gene-specific
primers (Supplemental Table S1). Primers were designed
using Primer 3 software (http://frodo.wi.mit.edu/primer3/)
upstream of the DeepSAGE peak or peaks. Genes for the
RT-qPCR validation were selected (1) by a high enough ex-
pression level for reliable detection by RT-qPCR (which cor-
responds to >100 raw counts per sample in at least one exper-
imental group) and (2) from the full range of p values consid-
ered significant (i.e. p=3.4×10−5 (Lsg15) to p=0.0045 (Ctsz)
for the ‘CSD effect’; 3.48×10−6 (Spp1) to p=0.0031 (Rsad2)
for cluster 1 of the ‘interaction effect’), which should provide
sufficient proof that the results of the whole list are valid.
Samples were analysed in duplicate, with Tbp and Gapdh as
housekeeping genes. The RT-qPCR data was analysed with
Bio-Rad CFXManager™ Software (version 3.0). Differential
expression was calculated using a one-way analysis of vari-
ance (ANOVA) and Bonferroni post-hoc test.
Comparison with Published Gene Expression Data
Genes with enriched expression in one of the brain cell types
(neurons, astrocytes, microglia or oligodendrocytes) under
basal conditions were identified using an in-depth literature
search [24–31]. To increase the specificity of the gene sets,
genes listed more than once were removed. Furthermore, we
identified genes differentially expressed after an inflammatory
stimulus in brain cell types (neurons, astrocytes andmicroglia)
as well as in macrophages (microglia-related cells). Enrich-
ment of genes from the cell type-enriched or stimulus-
related gene lists in cluster 1 (p value and odds ratio) was
calculated using a Fisher exact test.
Allen Brain Atlas
For spatial co-expression analysis in the healthy mouse brain
we obtained information from RNA in situ hybridisation de-
posited in the Allen Mouse Brain Atlas (http://www.brain-
map.org/) [32]. The data set contains probe expression
values summarised at the voxel level. Selection of only data
of the left hemisphere and filtering out voxels with more than
75 % missingness left 27,365 voxels and 26,022 probes of
19,909 genes. To obtain a gene co-expression network, cosine
similarities were calculated between all probes and the mean
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similarity per gene pair was taken. Of the 96 genes in cluster 1,
87 genes could be matched to Allen Brain Atlas data. To test
whether the spatial co-expression of cluster 1 was significant-
ly different from random gene sets, a random permutation test
was performed by drawing gene sets of the same size and
constructing a null distribution of the mean co-expression
value.
Results
DeepSAGE Sequencing in Cortical Mouse Brain Samples
that Were Subjected to Cortical Spreading Depression
The cortical transcriptome of FHM1 R192Q mutant and WT
mice was investigated using DeepSAGE sequencing, 24 h
after experimental induction of CSD or Sham surgery (N=6/
experimental group) (Fig. 1). Over 10 million high-quality
sequencing reads were obtained per sample (median per base
phred score was 31 or higher) of which on average 52 %
(range 45–57 %) could be uniquely aligned to known exons
in the mouse genome (Supplemental Table S2). Similar num-
bers of total reads and aligned reads were observed for the four
experimental groups (Supplemental Table S2). For each sam-
ple, the expression level per gene was calculated. A total of 23,
847 mouse genes could be detected in our dataset.
Cortical Spreading Depression Affects Expression
of Immune System-Related Genes
Cortical gene expression levels were compared between
FHM1 R192Q mutant and WT mice (‘genotype effect’) and
between the CSD- and Sham-treated groups (CSD effect).
Gene expression changes were modest. Therefore, we used a
less-stringent threshold of uncorrected p<0.005 and focused
our downstream analyses and interpretation of the data on
gene sets rather than individual genes to diminish the contri-
bution of false positives. Furthermore, extra effort was put in
validating promising results with RT-qPCR in an independent
group of animals. Only 45 genes showed a genotype effect
(Supplemental Table S3). The CSD effect was more pro-
nounced with 80 genes showing unadjusted p<0.005 (Sup-
plemental Table S4). A GO term enrichment analysis of the
CSD effect showed that biological functions and pathways
affected by CSD in the mice are largely involved in immune
system-related functions (Table 1).
Gene expression differences were validated byRT-qPCR in
biologically independent samples (N=6/experimental group)
for a selection of genes that showed a genotype effect or a
CSD effect (Supplemental Figs. S1 and S2). Since the major-
ity of the 45 genes that showed a genotype effect had a very
low expression level, we could select only three for validation
with RT-qPCR. Only one of them, Klk6, showed a significant
difference in expression level based on ANOVA testing,
whereas Bonferroni post hoc testing did not show differences
between both FHM1 R192Q mutant and WT groups, as
would be expected for a true difference between genotypes
(Supplemental Fig. S1). From the CSD effect set of 80 genes,
eight were selected for validation by RT-qPCR from which
six, Isg151, Cd180, Trim30a, Bst2, Samd9l and Ctsz, showed
significant differential expression in the RT-qPCR validation
(Supplemental Fig. S2).
Interaction Analysis Identifies Up-regulation
of Interferon-Related Genes After Cortical Spreading
Depression, Specifically in the Brains of FHM1 R192Q
Mutant Mice
A multifactorial model that included an interaction factor was
used to identify genes that responded differently to CSD in
FHM1 R192Q mutant and WT mice. Some 360 genes dem-
onstrated uncorrected p values <0.005 for the interaction fac-
tor (interaction effect) (Supplemental Table S5). In order to
identify sets of genes with similar expression patterns, genes
were classified into four clusters based on their expression
levels in the four experimental groups using k-means cluster
analysis (Fig. 2; Supplemental Table S5).
Subsequently, a GO term and pathway analysis was per-
formed on the genes from each cluster to determine whether
genes with similar expression patterns also have similar func-
tions (Fig. 2). Only cluster 1 showed a clear enrichment of
functional categories. The expression levels of the 95 genes
within this cluster were increased after CSD induction; more
strongly in brains of FHM1 R192Q mutant mice. GO term
analysis indicated that many genes from cluster 1 are involved
in immune system responses with several having a function in
the regulation of cell adhesion and motility. GO terms includ-
ed ‘immunity and defence’ (p=2.4×10−7), ‘interferon-medi-
ated immunity’ (p = 1.1 × 10−4) and ‘cytokine- and
Table 1 GO terms and pathways
significantly overrepresented in
the ‘CSD effect’ gene set
Category Term p value
PANTHER_BP_ALL BP00156: interferon-mediated immunity 6.12× 10−5
PANTHER_BP_ALL BP00148: immunity and defence 5.85× 10−4
PANTHER_BP_ALL BP00107: cytokine and chemokine mediated signalling pathway 2.14× 10−3
PANTHER_MF_ALL MF00173: defence/immunity protein 0.01
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Fig. 2 K-means clustering of the genes from the ‘interaction effect’.
Mean- and variance-normalised gene expression data of the 360 genes
from the interaction effect were clustered into four clusters with different
expression patterns over the four experimental groups (WT Sham-treated,
WT CSD-treated, FHM1 Sham-treated and FHM1 CSD-treated). Below
each cluster, enriched GO terms and their respective p values are shown.
The GO term enrichment was generated using DAVID, which classifies
genes for biological process (BP) and pathways from the PANTHER
subset of GO terms
Fig. 3 RT-qPCR validation of cluster 1 in biologically independent
samples. The selected genes from cluster 1 were all present in the
protein interaction network. Data were normalised to Tbp and Gapdh
mRNA expression and expressed as fold-changes relative to the WT
Sham-treated group (means ± SD). *p < 0.05; **p < 0.01; ***p < 0.001
according to a one-way ANOVAwith Bonferroni post-hoc test
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chemokine-mediated signalling pathway’ (p=1.3×10−3). A
selection of genes from cluster 1 was used for the validation
of the initial results by RT-qPCR in the set of independent
biological samples. Thirteen out of 15 analysed genes showed
significant differential expression between the four experi-
mental groups as measured with an ANOVA test (Fig. 3).
Most striking, all genes showed highest expression in the
FHM1 R192Q mutant CSD group, thereby replicating and
validating the DeepSAGE sequencing data.
To further explore the genes from cluster 1, the STRING
database for protein associations was used, which showed that
49 genes from this cluster (52 %) group together in a signifi-
cant protein association network largely based on co-
expression data and text mining (Fig. 4). Text mining associ-
ations from the protein association network indicated that
many genes from cluster 1 are involved in interferon-
mediated signalling. Therefore, we compared the genes from
cluster 1 to the Interferome database of interferon-regulated
genes and found that a striking 43 of the 95 genes from cluster
1 (44 %) are annotated as interferon-regulated genes (Fig. 4).
To further identify possible signalling cascades that could
have regulated the expression pattern of genes from cluster
1, a transcription factor binding site overrepresentation analy-
sis was performed that revealed that binding sites of 15 tran-
scription factors are overrepresented in the promoter regions
of the genes from cluster 1, including the interferon regulatory
factors 1 and 8 and STAT1/2 that are involved in interferon
signalling (Table 2).
Genes from Cluster 1 Are Not Co-expressed in Naïve
Mouse Brain
The protein association network analysis (Fig. 4) showed that
many genes from cluster 1 are co-expressed, but does not
specify whether the co-expression concerns a certain tissue
or cell type. Information from the Allen Brain Atlas gene
Fig. 4 Protein association network in cluster 1. The protein association
network is derived from the STRING database. The nodes represent the
genes from cluster 1. The connections between the nodes represent the
interactions based on co-expression (black), text mining (light green)
association in curated database (light blue) and high-throughput
experiments (pink). Nodes with bold circles represent interferon-
responsive genes from the Interferome database
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expression database was used to calculate the level of co-
expression of genes from cluster 1 in the naïve adult mouse
brain. Genes from cluster 1 appear to be significantly less
spatially co-expressed than random genes in the healthy
mouse brain (p=0.003) (Fig. 5), in line with the lower expres-
sion of the genes in the naïve brain. To identify cell types that
could be involved in the inflammatory response upon CSD in
our mice, genes from cluster 1 were compared with published
gene lists containing neuron-, astrocyte-, microglia- or
oligodendrocyte-enriched genes (Table 3) [24–26]. A smaller
than expected number of neuron- and oligodendrocyte-
enriched genes was found in cluster 1. Next, the gene list of
cluster 1 was compared with a lists of genes that appeared
differentially expressed after treatment with an inflammatory
trigger in several brain cell types and macrophages [25,
27–31]. A significantly higher than expected number of 39
genes out of 95 of cluster 1 overlap with this gene list
(p=2.20×10−16) (Table 3).
Discussion
Here we investigated the molecular effects of CSD, as a sur-
rogate for migraine with aura, on gene expression level in a
well-validated migraine mouse model [13]. Gene expression
changes were investigated 24 h after CSD induction (or Sham
treatment)—to avoid confounding influences of the surgery
and anaesthesia—in cortical tissue of FHM1 R192Q mutant
mice and WT mice to assess whether long-lasting and/or de-
layed changes in molecular mechanisms occurred in response
to CSD. Three sets of differentially expressed genes were
identified: (i) genes with differential expression between ge-
notypes (genotype effect); (ii) genes with differential
Table 2 Transcription factor
binding site overrepresentation in
cluster 1
TF binding site Transcription factor Study freq. Random freq. p value
IRF_Q6 a Interferon regulatory factor 1 0.20 0.12 6.41× 10−3
KAISO_01 Zinc finger and BTB domain
containing 33
0.38 0.27 7.79× 10−3
NFE2_01 Nuclear factor, erythroid derived 2 0.34 0.24 7.82× 10−3
BACH2_01 BTB and CNC homology 2 0.16 0.09 8.41× 10−3
YY1_01 YY1 transcription factor 0.98 0.93 9.29× 10−3
CACBINDING-
PROTEIN_Q6
Not matched to known
transcription factor
0.74 0.64 0.01
ISRE_01 a Signal transducer and activator
of transcriptions 1 and 2
0.19 0.12 0.01
AP1_01 Jun oncogene 0.96 0.90 0.01
ICSBP_Q6 a Interferon regulatory factor 8 0.16 0.10 0.01
XFD3_01 Forkhead box A2 0.93 0.87 0.01
STAT5B_01 Signal transducer and activator
of transcription 5B
0.29 0.20 0.02
TFIII_Q6 General transcription factor IIA,
1 and 2
0.82 0.75 0.04
AP4_01 Transcription factor AP-4 0.38 0.31 0.05
MAZ_Q6 MYC-associated zinc finger protein
(purine-binding transcription factor)
0.51 0.43 0.05
HTF_01 X-box binding protein 1 0.50 0.42 0.05
a Transcription factors and their binding sites directly involved in interferon-mediated signalling
Fig. 5 Co-expression analysis of cluster 1 genes in the naïve mouse
brain. The naïve mouse brain expression data were retrieved from the
Allen Brain Atlas. Genes with a high cosine similarity have similar
spatial expression patterns. Cosine similarities between genes from
cluster 1 are compared to those between randomly drawn gene sets of
the same size, using their cumulative density functions. The mean
similarity between cluster 1 genes is significantly lower than that of
randomly drawn gene sets. Cdf cumulative distribution function
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expression between CSD induction and Sham surgery (CSD
effect); and (iii) genes that show an interaction between geno-
type and CSD induction (interaction effect).
The genotype effect was only limited. This is in line with
our previous study that identified only minor differences in
cortical gene expression between FHM1 mice and WT under
naïve conditions [20]. Also, the CSD effect was relatively
small, which shows that the brain is relatively resistant with
respect to changing the expression of genes even after a major
perturbation such as multiple CSD events. The inflammation-
related genes in the CSD effect are not unexpected, as CSD
induction is known to activate inflammatory signalling cas-
cades already within minutes [8] but also with a time delay of
hours that can last for days [9–12]. In addition, CSD induction
is known to cause long-term activation of microglia [33]. As
for our gene expression analysis, we only investigated the 24 h
time point after CSD. It needs to be established whether addi-
tional CSD-induced FHM1-specific gene expression changes
occur at later time points. This may well be the case as certain
inflammatory genes such as Cd74, Lgals3 and Timp1 [12]
have been shown to take longer to become expressed or up-
regulated upon experimentally induced spreading depression.
Moreover, (presumed) downstream effects of inflammatory
changes related to myelin were observed up to 3 days follow-
ing SD [34] and related to activation of brain regions 40 h
following CSD [35]. Still, since a microarray gene expression
study investigating WT rats that underwent CSD showed less
profound changes at time points later than 24 h following
CSD [12], we feel that the 24 h time point sufficiently cap-
tured relevant gene expression differences induced by CSD.
The observation of an up-regulation of inflammatory genes
after CSD in comparison to the Sham-treated group suggests
minor influence of surgical procedures or post-surgery
analgesia.
The most remarkable finding of the study was the up-
regulation of a set of genes after CSD specifically in FHM1
R192Q mutant brains (cluster 1 from the interaction effect).
These genes show a strong functional enrichment for genes
involved in inflammatory signalling. Several genes in cluster
1 (Cd53, Ms4a6d, Anxa2, Ccl2, Vim, C3ar1 and Timp1) are
key drivers of inflammatory reactions [36]. The high abun-
dance of genes from cluster 1 in the Interferome database of
interferon-regulated genes, as well as the overrepresentation
of interferon-related transcription factor binding sites (IRF,
ISRE and ICSBP) in the promoter regions of these genes,
indicate a major role for interferon-mediated inflammatory
signalling in the response to CSD that is specific for FHM1
R192Q mutant mice. A clear role for interferon-related re-
sponses in migraine pathophysiology has not yet been
identified.
Remarkably, genes from cluster 1 showed reduced co-
expression in the naïve mouse brain but increased co-
expression in brain-related cell types that were subjected to a
strong, inflammatory, stimulus. This suggest that the up-
regulation of genes in cluster 1 is truly stimulus dependent.
Notably, a meta-analysis of gene expression studies of respi-
ratory virus infections revealed that expression of multiple
genes from cluster 1, e.g. Ifit3, Tgfbi and Igtp, is positively
correlated with the severity of infection [37], suggesting that
these genes are markers of severity of inflammatory re-
sponses. Furthermore, 11 out of 95 genes from cluster 1 have
been found to be differentially expressed also upon induction
in experimental animals of status epilepticus and traumatic
brain injury; two widely used models with triggers that should
be considered more severe than CSD [38]. The altered expres-
sion of cluster 1 genes could therefore reflect that CSD might
evoke a more dramatic response in the brains of FHM1
R192Q mutant mice than in WT mice. The dramatic response
seems a direct consequence of the presence of mutated CaV2.1
calcium channels [15, 17]. Future studies in FHM1 S218L
mice, which express a more severe mutation that results in
an even more enhanced gain-of-function of CaV2.1 channels
and CSD susceptibility with additional neurological symp-
toms including seizures and cerebellar ataxia [39], may ad-
dress whether the identified changes in gene expression in
FHM1 R192Q are more pronounced when CaV2.1 channel
activity is more affected. Also, due to the associated neuro-
logical deficits additional gene pathways may be revealed.
How this interaction between CSD and the FHM1 R192Q
mutation would result in a specific inflammatory profile re-
mains to be identified. Studies in epilepsy models already
hinted at a close interplay between enhanced excitatory activ-
ity and inflammation [40, 41], which suggests that the en-
hanced glutamatergic activity in FHM1 R192Q mutant mice
[17] that is more pronounced during CSD episodes may trig-
ger a particularly severe inflammatory response. Alternatively,
Table 3 Cell type specificity of
genes from cluster 1 Total count Study count p value Odds ratio References
Neuron-enriched genes 2436 3 0.01 0.27 [24, 26]
Astrocyte-enriched genes 2261 13 0.23 1.43 [24, 26]
Microglia-enriched genes 85 2 0.05 5.80 [25, 26]
Oligodendrocyte-enriched genes 1932 2 0.02 0.23 [24, 26]
Immune stimulation-responsive
genes
1647 39 2.20× 10−16 8.88 [25, 27–31]
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one can speculate that the enhanced inflammatory response to
CSD may be the result of a pro-inflammatory state in the
brains of FHM1 R192Q mutant mice that may already exist
in naïve animals. In that respect, it is noteworthy that naïve
trigeminal ganglia of FHM1 R192Q migraine mice exhibit a
pro-inflammatory phenotype with a higher number of activat-
ed macrophages, activated microglia and increased cytokine
expression levels [42–45]. In the caudal cortex, in which CSD
events originate, only nine genes are differently expressed in
naïve FHM1 mutant mice [20]. Of those genes, Camkk1,
Gpr34, Tom1l2 and Cort are linked to inflammation, thus
providing some evidence that a pro-inflammatory state may
also exist in the naïve FHM1 R192Q cortex. Finally, changes
in vascular permeability and possible intrusion of white blood
cells might be involved in the inflammatory state of the brain
after CSD induction. CSD has previously been shown to cause
opening of the blood brain barrier (BBB) through activation of
the proteinase MMP9 in rats [46]. In addition, in rat hippo-
campal slices, spreading depression was shown to cause ab-
normal interferon signalling through activation of T cells [34].
Although the CSD effect and cluster 1 of the interaction effect
do not contain markers for white blood cells, increased BBB
permeability and possibly subsequent white blood cell intru-
sion may provide an attractive explanation for the enhanced
interferon-related inflammatory signature in FHM1 R192Q
mice after CSD. The identification of an increased specific
inflammatory response after CSD in a relevant migraine
mouse model raises the question whether CSD in FHM1
R192Q mice may lead to an increased activation of meningeal
nociceptors and trigeminal ganglia, which would drive the
activation of pain-related brain structures ultimately causing
migraine headache [6–8].
In summary, CSD caused a specific inflammatory signal-
ling response in the cortex of FHM1 R192Q mutant mice.
First evidence now emerges that a possible pro-
inflammatory state in the naïve brain of FHM1 R192Q mice
may lead to an exacerbated inflammatory reaction, in response
to a strong stimulus like CSD. Pathway analyses suggest that
this exacerbated inflammatory reaction is interferon related.
This study suggests that interferon plays an important role in
the effects of CSD and reinforces the concept that neuro-
inflammation may play an important role in migraine
pathophysiology.
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